Bioplatinum Technologies LLC

Overview

Bioplatinum Technologies develops precision medicines targeting sulfated glycosaminoglycans (GAGs) to overcome cancer resistance and block viral entry.

Classification

This U.S. industry comprises establishments primarily engaged in (1) manufacturing uncompounded medicinal chemicals and their derivatives (i.e., generally for use by pharmaceutical preparation manufacturers) and/or (2) grading, grinding, and milling uncompounded botanicals.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Medicinal and Botanical Manufacturing325411

Capabilities